Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bavarian Nordic R/I ADR (OP:BVNRY)

9.445 +0.095 (+1.02%)
Streaming Delayed Price Updated: 12:52 PM EDT, Jun 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bavarian Nordic R/I ADR

< Previous 1 2 3 Next >
News headline image
Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch ↗
The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply. 
Via Benzinga
News headline image
Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test ↗
 
Via Benzinga
News headline image
Bavarian Nordic Recruits US Firm For Packaging Services For Its Monkeypox Vaccine ↗
 
Via Benzinga
News headline image
Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment ↗
Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments. 
Via Benzinga
News headline image
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher ↗
These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up. 
Via InvestorPlace
News headline image
Bavarian Nordic's Monkeypox Vaccine Gets Thumbs Up From EU Regulator ↗
 
Via Benzinga
News headline image
EU, Bavarian Nordic Ink Supply Pact For 110,000 Monkeypox Vaccines ↗
 
Via Benzinga
News headline image
The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand ↗
Bavarian Nordic A/S (OTC: BVNKF), the only company with an approved vaccine for monkeypox, said it’s no longer sure it can meet demand as cases continue to rise worldwide, 
Via Benzinga
News headline image
Plan To Extend Supply Of Monkeypox Vaccine On Cusp Of Emergency Clearance: Report ↗
A plan to extend the limited supply of monkeypox vaccine in order to provide additional doses may soon be receiving emergency clearance by U.S. health officials. 
Via Benzinga
News headline image
3 Monkeypox Stocks to Buy as Biden Declares Public Health Emergency ↗
Monkeypox stocks are about to rise now that the White House has declared the virus a public health emergency. Here are the stocks to watch. 
Via InvestorPlace
News headline image
VRAX Stock Alert: Why Is Virax Biolabs Up 120% Today? ↗
With monkeypox infections rising, Virax Biolabs’ PCR test for the underlying virus is bolstering sentiment for VRAX stock. 
Via InvestorPlace
News headline image
Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak ↗
The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care... 
Via Benzinga
News headline image
Why Is SIGA Technologies (SIGA) Stock Plunging 23% Today? ↗
SIGA stock is sinking lower after the FDA released a report, stating that TPOXX has not demonstrated efficacy in humans against monkeypox. 
Via InvestorPlace
News headline image
Monkeypox Stocks SIGA, GOVX, BVNRY, CHMX, EBS Soar on Global Health Emergency ↗
Drugs and vaccines used against smallpox are seen as the first line of defense against the rising tide of monkeypox infections. 
Via InvestorPlace
News headline image
SIGA Stock Soars as WHO Declares Monkeypox Global Health Emergency ↗
It's not every day that SIGA stock trends in the financial media, but today vaccine stocks are in focus due to the spread of monkeypox. 
Via InvestorPlace
News headline image
Bavarian Nordic's Monkeypox Vaccine Scores EU Approval As WHO Declares Global Health Emergency ↗
 
Via Benzinga
News headline image
Benzinga Before The Bell: Snap's Dismal Earnings, Amazon's Healthcare Foray, Robinhood Moves 41B Dogecoin Into Single Wallet And Other Top Financial Stories Friday, July 22 ↗
Reuters 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Bavarian Nordic Inks Multiple Supply Pact For Its Monkey pox Vaccine, Updates FY22 Guidance ↗
 
Via Benzinga
News headline image
Lawmaker Warns San Francisco Faces 'Public Health Mess' Over Monkeypox Vaccine Shortage ↗
A California state legislator representing the Bay Area declared San Francisco is "veering toward a public health mess" after the city’s Department of Public Health acknowledged it is running out of... 
Via Benzinga
News headline image
Quest Diagnostics Unveils Monkeypox Test: What You Need To Know ↗
Quest Diagnostics (NYSE: DGX) has announced the nationwide availability of a lab-developed, automated molecular diagnostic test to identify if a person is infected with monkeypox. 
Via Benzinga
News headline image
20% Of US Monkeypox Cases Are In This City ↗
New York City has become the monkeypox capital of the U.S., with nearly 20% of the nation’s reported cases. What Happened: According to the New York Post, the city recorded 119 cases as of Wednesday.... 
Via Benzinga
News headline image
Monkeypox Stocks BVNRY, EBS, CMRX, SIGA Heat Up on U.S. Vaccine Stockpile ↗
Pharmaceutical companies that make vaccines against monkeypox are getting attention as demand for treatments against the virus grow. 
Via InvestorPlace
News headline image
White House Outlines New Monkeypox Vaccine Strategy: What You Need To Know ↗
 
Via Benzinga
News headline image
Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot ↗
 
Via Benzinga
News headline image
Morning Brief: Top Financial Stories Dominating on Tuesday, June 14 ↗
CNBC 
Via Benzinga
News headline image
7 Monkeypox Stocks That May Take Off in Q2 ↗
SIGA Technologies (SIGA) may lead on the list of Monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race. 
Via InvestorPlace
News headline image
Why Is AIkido Pharma (AIKI) Stock Up 1,400%? ↗
AIkido Pharma (AIKI) stock is skyrocketing on Tuesday but it's not due to any positive news from the biotechnology company. 
Via InvestorPlace
News headline image
Bavarian Nordic (BVNRY) Stock Gets a Boost From New Canadian Contract ↗
Bavarian Nordic (BVNRY) stock is rising higher on Tuesday after announcing a new deal with Canada to purchase one of its vaccines. 
Via InvestorPlace
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.